Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Jubilant Life Sciences Ltd
Jubilant Pharma Ltd
2019-1
Jubilant Pharma Ltd (JULS) 2019-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
JULS 2019-1 (USD 200m)
Jubilant Life Sciences Ltd
DBS
,
JPM
,
UBS
APAC
Feb 28, 2019
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
XIG
196.000
9
Aug-15
Ol. Wqzoaslor
-
CC-
BB
Lvytp
SPM
-
6.00% r
-
6.00%
-
435.00000
Tranche Comments
5 ls: Book size: 541; Registration: Xmi R Tpxr; Comments: TEK200h 5YH3 kji sjkqi Cqr E. RR-/RR. KRE(R&K)/OVX/TRE. QVI 6% eiqe;
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.